CAJ | 학술논문

目的分析20%人血白蛋白胸腔内注射治疗顽固性气胸的临床价值。方法选取2010年1月～2012年11月在我院进行治疗的顽固性气胸患者36例，分为两组，分别采用20%人血白蛋白胸腔内注射的方法治疗和高渗糖治疗。结果实验组中20%人血白蛋白治愈率为94.4%，高于对照组的83.3%并且仅有3例患者出现轻度的疼痛，低热患者为2例，无重度胸痛的患者，疗效明显好于传统的高渗糖组。结论20%人血白蛋白可以应用于顽固性气胸的治疗，且操作简便易于掌握，可在临床上进一步推广。
목적분석20%인혈백단백흉강내주사치료완고성기흉적림상개치。방법선취2010년1월～2012년11월재아원진행치료적완고성기흉환자36례，분위량조，분별채용20%인혈백단백흉강내주사적방법치료화고삼당치료。결과실험조중20%인혈백단백치유솔위94.4%，고우대조조적83.3%병차부유3례환자출현경도적동통，저열환자위2례，무중도흉통적환자，료효명현호우전통적고삼당조。결론20%인혈백단백가이응용우완고성기흉적치료，차조작간편역우장악，가재림상상진일보추엄。
Objective This Study aims to analyze the clinical value of 20% human serum albumin on intractable pneumothoraxby intrapleural injection. Methods 36 cases of intractable pneumothorax patients who were admitted into our hospital from Jan. 2010 to Nov. 2012 were divided into two groups, and treated with 20% human serum albuminby intrapleural injection and hyperosmotic glucose respectively. Results The recovery rate of experimental group treated by 20% human serum albumin was 94.4%, the curative effect was superior to control group which was 83.33%. Only 3 cases of mild pain and 2 cases of low-grade fever occurred, meanwhile, no patients got severe chest pain. The curative effect of 20% human serum albumin was superior to hyperosmotic glucose. Conclusion 20%human serum albumin can be applied in the treatment of intractable pneumothorax, it has a characteristic of easy operation and learnability,and worth to be promoted in clinical therapy.